Categorical shift analysis of absolute change in per cent predicted FVC during two consecutive 6-month intervals in the pooled placebo population
| Month 6 to month 12 | |||||||
|---|---|---|---|---|---|---|---|
| Patients, n (%)* | FVC stable or improved | FVC decline >0 to <10% | FVC decline ≥10% | Death | Missing† | Total, n | |
| Baseline to month 6 | FVC stable or improved | 32 (19.8) | 102 (63.0) | 19 (11.7) | 2 (1.2) | 7 (4.3) | 162 |
| FVC decline >0 to <10% | 117 (31.7) | 213 (57.7) | 17 (4.6) | 6 (1.6) | 16 (4.3) | 369 | |
| FVC decline ≥10% | 16 (27.1) | 17 (28.8) | 7 (11.9) | 13 (22.0) | 6 (10.2) | 59 | |
| Death | 0 | 0 | 0 | 19 (100) | 0 | 19 | |
| Missing† | 0 | 0 | 0 | 1 (6.7) | 14 (93.3) | 15 | |
| Total, n | 165 | 332 | 43 | 41 | 43 | 624 | |
*Percentages represent proportion of patients in the same row.
†Missing due to reasons other than death.